Items where authors include "Muranen, T.A."

Export as [feed] Atom [feed] RSS
Jump to: Article
Number of items: 16.

Article

Morra, A. orcid.org/0000-0003-4983-7883, Schreurs, M.A.C. orcid.org/0000-0002-1826-5344, Andrulis, I.L. et al. (114 more authors) (2023) Association of the CHEK2 c.1100delC variant, radiotherapy, and systemic treatment with contralateral breast cancer risk and breast cancer-specific survival. Cancer Medicine. ISSN 2045-7634

Guo, Q., Burgess, S., Turman, C. et al. (132 more authors) (2017) Body mass index and breast cancer survival: a Mendelian randomization analysis. International Journal of Epidemiology, 46 (6). pp. 1814-1822. ISSN 0300-5771

Muranen, T.A., Greco, D., Blomqvist, C et al. (10 more authors) (2016) Genetic modifiers of CHEK2*1100delC-associated breast cancer risk. Genetics in Medicine. ISSN 1098-3600

Schmidt, M.J., Cox, A. orcid.org/0000-0002-5138-1099, Hogervorst, F. et al. (81 more authors) (2016) Age- and Tumor Subtype-Specific Breast Cancer Risk Estimates for CHEK2*1100delC Carriers. Journal of Clinical Oncology, 34 (23). pp. 2750-2760. ISSN 0732-183X

Hollestelle, A., van der Baan, F.H., Berchuck, A. et al. (355 more authors) (2016) No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer. Gynecologic Oncology, 141 (2). pp. 386-401. ISSN 0090-8258

Guo, Q., Schmidt, M.K., Kraft, P. et al. (143 more authors) (2015) Identification of Novel Genetic Markers of Breast Cancer Survival. Journal of the National Cancer Institute, 107 (5). ISSN 0027-8874

Mavaddat, N., Pharoah, P.D.P., Michailidou, K. et al. (209 more authors) (2015) Prediction of Breast Cancer Risk Based on Profiling With Common Genetic Variants. JNCI-Journal of the National Cancer Institute, 107 (5). ISSN 0027-8874

Pirie, A., Guo, Q., Kraft, P. et al. (146 more authors) (2015) Common germline polymorphisms associated with breast cancer-specific survival. Breast Cancer Research, 17. 58. ISSN 1465-5411

Michailidou, K., Beesley, J., Lindstrom, S. et al. (245 more authors) (2015) Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer. Nature Genetics, 47. pp. 373-380. ISSN 1061-4036

Spurdle, A.B., Couch, F.J., Parsons, M.T. et al. (195 more authors) (2014) Refined histopathological predictors of BRCA1 and BRCA2 mutation status: a large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortia. Breast Cancer Research, 16. 3419. ISSN 1465-5411

Milne, R.L., Burwinkel, B., Michailidou, K. et al. (178 more authors) (2014) Common non-synonymous SNPs associated with breast cancer susceptibility: findings from the Breast Cancer Association Consortium. Human Molecular Genetics, 23 (22). pp. 6096-6111. ISSN 0964-6906

Khan, S., Greco, D., Michailidou, K. et al. (161 more authors) (2014) MicroRNA Related Polymorphisms and Breast Cancer Risk. PLOS ONE, 9 (11). e109973. ISSN 1932-6203

Johnson, N., Dudbridge, F., Orr, N. et al. (182 more authors) (2014) Genetic variation at CYP3A is associated with age at menarche and breast cancer risk: a case-control study. Breast Cancer Research , 16 (3). R51. ISSN 1465-5411

Sawyer, E., Roylance, R., Petridis, C. et al. (151 more authors) (2014) Genetic Predisposition to In Situ and Invasive Lobular Carcinoma of the Breast. PLoS Genetics, 10 (4). e1004285. ISSN 1553-7390

Agarwal, D., Pineda, S., Michailidou, K. et al. (179 more authors) (2014) FGF receptor genes and breast cancer susceptibility: results from the Breast Cancer Association Consortium. British Journal of Cancer, 110 (4). pp. 1088-1100. ISSN 0007-0920

Couch, F.J., Wang, X., McGuffog, L. et al. (267 more authors) (2013) Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk. PLoS Genetics, 9 (3). e1003212. ISSN 1553-7390

This list was generated on Sun Mar 24 09:52:23 2024 GMT.